360 NEWS360 NEWS

Healthcare ยท National

Gilead signs generic licensing deals for experimental Ebola drug

A late-stage trial is testing the drug in people at high risk after exposure. The deals are intended to line up manufacturing and supply before trial results and regulatory filings

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on โ€œGilead signs generic licensing deals for experimental Ebola drugโ€?

This is self-selected reader participation, not representative scientific polling.